BE904059A - Utilisation de derives d'isoquinoleine et de leurs sels pour la production de compositions pharmaceutiques - Google Patents

Utilisation de derives d'isoquinoleine et de leurs sels pour la production de compositions pharmaceutiques

Info

Publication number
BE904059A
BE904059A BE0/216148A BE216148A BE904059A BE 904059 A BE904059 A BE 904059A BE 0/216148 A BE0/216148 A BE 0/216148A BE 216148 A BE216148 A BE 216148A BE 904059 A BE904059 A BE 904059A
Authority
BE
Belgium
Prior art keywords
production
salts
pharmaceutical compositions
treatment
release
Prior art date
Application number
BE0/216148A
Other languages
English (en)
Inventor
K Umezu
S Yuasa
Y Morita
M Taniguchi
T Nomura
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Publication of BE904059A publication Critical patent/BE904059A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procédé pour la préparation d'un médicament pour l'emploi dans un traitement inhibant la formation de peroxydes de lipides, la libération des enzymes lysosomiales, la production d'oxygène actif et/ou la libération d'histamine et procédé pour le traitement des affections associées à la formation de peroxydes de lipides et également un procédé perfectionné pour le traitement des affections hépatiques, lesdits procédés comprenant l'administration de quantités efficaces d'un dérivé d'isoquinoléine représenté par la formule générale I.
BE0/216148A 1985-01-17 1986-01-17 Utilisation de derives d'isoquinoleine et de leurs sels pour la production de compositions pharmaceutiques BE904059A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69230985A 1985-01-17 1985-01-17

Publications (1)

Publication Number Publication Date
BE904059A true BE904059A (fr) 1986-07-17

Family

ID=24780061

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216148A BE904059A (fr) 1985-01-17 1986-01-17 Utilisation de derives d'isoquinoleine et de leurs sels pour la production de compositions pharmaceutiques

Country Status (6)

Country Link
EP (1) EP0201359A3 (fr)
JP (2) JPS61165326A (fr)
BE (1) BE904059A (fr)
CH (2) CH677731A5 (fr)
FR (1) FR2578164B1 (fr)
IT (1) IT1213024B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63270678A (ja) * 1987-04-30 1988-11-08 Mitsui Petrochem Ind Ltd 新規含窒素化合物
US20050049278A1 (en) * 2003-08-27 2005-03-03 Youssef Bennani Benzo[1,3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and using the same
CN101735229A (zh) * 2009-12-24 2010-06-16 沈阳药科大学 四氢异喹啉类化合物及其制备方法和用途
FR3111071B1 (fr) * 2020-06-04 2023-01-13 H4 Orphan Pharma Utilisation de ligands multifonctionnels pour traiter les syndromes de détresse respiratoire et le choc cytokinique liés aux infections virales à coronavirus.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1206909B (de) * 1959-08-14 1965-12-16 Maurice Jeanson Verfahren zur Herstellung von Inhibitoren der Histidindecarboxylase
FR2424271A1 (fr) * 1978-04-28 1979-11-23 Laire Chimie Sa De Derives de phtalidyl-isoquinoleines, leur preparation et leur application comme medicaments
EP0028279B1 (fr) * 1979-10-22 1983-02-16 Calaire Chimie S.A. Dérivés de phtalidyl-isoquinoléines, leur préparation et leur application comme médicaments

Also Published As

Publication number Publication date
EP0201359A3 (fr) 1989-07-19
FR2578164A1 (fr) 1986-09-05
JPS61165326A (ja) 1986-07-26
CH677731A5 (en) 1991-06-28
JPS61165327A (ja) 1986-07-26
CH670642A5 (fr) 1989-06-30
FR2578164B1 (fr) 1990-08-10
IT1213024B (it) 1989-12-07
EP0201359A2 (fr) 1986-11-12
IT8619100A0 (it) 1986-01-17

Similar Documents

Publication Publication Date Title
US6593339B1 (en) Use of compounds as antibacterial agents
EP0280999A2 (fr) Compositions pharmaceutiques stabilisées contenant des inhibiteurs de l'enzyme de conversion de l'angiotensine
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
JPS62158210A (ja) Ｌ−ド−パの直腸吸収形態
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
KR970025615A (ko) 암 전이 억제제
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
BE904196A (fr) Preparations pharmaceutiques a activite analgesique, ainsi que leur fabrication et leur utilisation.
TNSN89039A1 (fr) Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales
DZ1324A1 (fr) Dérivés de céphalosporine, procédé pour leur préparation compositions pharmaceutiques les contenant et leur utilisation dans le traitement d'infections bactériennes.
DK562488A (da) Farmaceutisk praeparat indeholdende polyminderivater, samt nogle af disse polyaminderivater
BE904059A (fr) Utilisation de derives d'isoquinoleine et de leurs sels pour la production de compositions pharmaceutiques
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
ES2066134T3 (es) Usos farmaceuticos de acidos grasos.
KR870007937A (ko) 2β-치환된 티오 메틸페니실린 유도체 및 그의 제조방법 및 용도
EP0543855A1 (fr) Utilisation de composes d'aryle hydroxyuree pour le traitement de l'atherosclerose
KR890004705A (ko) 항바이러스성 제제
US4483854A (en) Systemic treatment of psoriasis using certain salicylates
EP0545805A1 (fr) Utilisation de la D-fenfluramine et de dérivés de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-résistants
FR2408589A1 (fr) Nouvelles 13,14-bisdeshydroprostaglandines, leur procede de preparation et leurs applications therapeutiques
BE1000719A4 (fr) Derives de 3-(hydroxymethyl)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant.
BE900780A (fr) DERIVES DE LA CHLORO-4-FURO (3,4-c)-PYRIDINE, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES DERIVES.
US4663345A (en) Etodolac for treatment of gout
IT1228537B (it) Derivati della cisteina ad azione espettorante
FR2430767A1 (fr) Nouvelles compositions pharmaceutiques a action hypotensive accrue

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MITSUBISHI HASEI CORP.

Effective date: 19930131